Haemodynamic management during hyperthermic intraperitoneal chemotherapy: A systematic review - 08/06/20

Doi : 10.1016/j.accpm.2020.03.019

Lucillia Bezu ^a,^c,⁎ , Mégane Raineau ^a, Myriam Deloménie ^b,^c, Bernard Cholley ^a,^c,^d, Romain Pirracchio ^a,^c
^a Service d’anesthésie, hôpitaux universitaires Paris Ouest, hôpital européen Georges Pompidou, Assistance publique–Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France
^b Service de chirurgie cancérologique gynécologique et du sein, hôpitaux universitaires Paris Ouest, hôpital européen Georges Pompidou, Assistance publique–Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France
^c Université Paris Descartes, Sorbonne Paris Cité, Paris, France
^d Inserm UMR S1140, Paris, France

^⁎Corresponding author at: Service d’anesthésie, hôpitaux universitaires Paris Ouest, hôpital européen Georges Pompidou, Assistance publique–Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France.Service d’anesthésie, hôpitaux universitaires Paris Ouest, hôpital européen Georges Pompidou, Assistance publique–Hôpitaux de Paris20, rue LeblancParis75015France

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Monday 08 June 2020
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Context

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a surgical technique for peritoneal carcinomatosis combining cytoreduction surgery and peritoneal irrigation of cytotoxic agents responsible for haemodynamics and fluid homeostasis alterations. To this day, no guidelines exist concerning intraoperative management.

Objectives

To review data on haemodynamic monitoring and management of patients undergoing HIPEC and to help design a standardised anaesthetic protocol.

Data sources

MEDLINE, EMBASE and Cochrane library were searched using the following.

Study selection

Original articles and case-reports. Letters to editors and reviews were excluded.

Data extraction

Data on haemodynamic management, morbidity and mortality.

Data synthesis

Haemodynamic management during HIPEC is highly variable and depends on local protocols. Only one randomised controlled trial evaluated the benefit of goal-directed fluid administration (GDFA). GDFA guided by advanced haemodynamic monitoring resulted in significantly less complication, shorter length of stay and less mortality compared to standard fluid administration. Renal protection protocol did not decrease the risk of acute kidney injury (AKI).

Conclusion

Our review reveals that fluid administration guided by advanced monitoring seems to be associated with less postoperative morbidity and mortality after HIPEC. Nevertheless, the literature review shows that intraoperative haemodynamic management is highly variable for this surgery. The use of renal protection strategy does not decrease the prevalence of AKI. Further prospective trials comparing different fluid management and haemodynamic monitoring strategies are urgently needed (PROSPERO registration CRD42018115720)

Le texte complet de cet article est disponible en PDF.

Keywords : Hyperthermic intraperitoneal chemotherapy, Anaesthesia, Fluid administration, Haemodynamic monitoring, Management